PEARW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 May 2024 @ 16:00):

Stats
Today's Volume	470 418
Average Volume	0
Market Cap	0.00
EPS	$0.210 ( Q4 \| 2023-03-31 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 31.08
ATR14	$0.0240 (406.78%)

ACONW 13.35%

AKLI -0.07%

BEATW -10.00%

BFRG -1.14%

BFRGW -12.15%

BTSG 4.99%

BTSGU 5.87%

CCLD -3.52%

CCLDO 3.02%

CCLDP -0.98%

CERN 0.00%

CHNG 0.26%

CMAXW -6.00%

ETAO -31.79%

EUDA -26.38%

EUDAW 16.53%

GEHC -1.14%

GEHCV -4.08%

INOV 0.14%

KERNW 0.00%

LIFW -2.17%

MGRX -5.88%

MSPR 0.00%

MSPRV -11.57%

MSPRW 0.00%

MSPRZ 0.00%

MTBC 12.19%

MTBCO 0.16%

MTBCP -0.28%

ONMD -1.75%

OTRKP 10.34%

PEARW 0.00%

SHCRW -3.26%

SHLT -5.62%

Insider Trading

Date	Person	Action	Amount	type
2023-04-10	5am Partners Iv, Llc	Sell	3 172 769	Class A Common Stock
2023-04-10	5am Partners Iv, Llc	Sell	534 855	Class A Common Stock
2023-02-15	Snow Ellen	Buy	199 864	Restricted Stock Units
2023-02-16	Snow Ellen	Buy	40 000	Restricted Stock Units
2023-02-15	Brenner Erin K.	Buy	952 380	Restricted Stock Units

INSIDER POWER
33.29
Last 93 transactions
Buy: 32 556 402 \| Sell: 10 288 531

Volume Correlation

Long: -0.42 (neutral)

Short: -0.95 (very strong negative)

Signal:(33.773) Neutral

Pear Therapeutics, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pear Therapeutics, Inc. Correlation - Currency/Commodity

0.65
( moderate )

0.66
( moderate )

0.00
( neutral )

-0.07
( neutral )

-0.67
( moderate negative )

0.08
( neutral )

Pear Therapeutics, Inc. Financials

Annual	2022
Revenue:	$12.69M
Gross Profit:	$4.51M (35.54 %)
EPS:	$-0.170

FY	2022
Revenue:	$12.69M
Gross Profit:	$4.51M (35.54 %)
EPS:	$-0.170

FY	2021
Revenue:	$4.21M
Gross Profit:	$-1.03M (-24.36 %)
EPS:	$0

Financial Reports:

No articles found.

Pear Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Pear Therapeutics, Inc.

Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.